A proof of concept, dose escalation study to evaluate plasmatic concentration of sorafenib.
Phase of Trial: Phase IV
Latest Information Update: 20 Jul 2015
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer; Renal cancer; Thyroid cancer
- Focus Proof of concept; Therapeutic Use
- 20 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.